KR100979347B1 - 항진균 조성물 - Google Patents
항진균 조성물 Download PDFInfo
- Publication number
- KR100979347B1 KR100979347B1 KR1020090025399A KR20090025399A KR100979347B1 KR 100979347 B1 KR100979347 B1 KR 100979347B1 KR 1020090025399 A KR1020090025399 A KR 1020090025399A KR 20090025399 A KR20090025399 A KR 20090025399A KR 100979347 B1 KR100979347 B1 KR 100979347B1
- Authority
- KR
- South Korea
- Prior art keywords
- composition
- skin
- antifungal composition
- terbinafine
- present
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Abstract
Description
구분 | 성분 | 실시예 1 함량(mg) |
실시예 2 함량(mg) |
실시예 3 함량(mg) |
(1) | 트리메틸실옥시실리케이트 | 72 | 78 | 90 |
(2) | 디메티콘 | 48 | - | - |
메틸트리메티콘 | - | 42 | - | |
에틸트리실록산 | - | - | 30 | |
(3) | 에탄올 | 800 | 800 | 800 |
(4) | 염산테르비나핀 | 11.25 | 11.25 | 11.25 |
(5) | 엘-멘톨 | 30.00 | 30.00 | 30.00 |
(6) | 이소프로필미리스테이트 | 13.75 | 13.75 | 13.75 |
(7) | 하이드록시프로필셀룰로오스 | 25.00 | 20.00 | 20.00 |
에틸셀룰로오스 | - | 5.00 | - | |
폴리비닐피롤리돈 | - | - | 5.00 |
구분 | 성분 | 실시예 4 함량(mg) |
실시예 5 함량(mg) |
실시예 6 함량(mg) |
실시예 7 함량(mg) |
실시예 8 함량(mg) |
(1) | 데카메틸시클로펜타실록산 | 360 | - | - | 360 | - |
폴리디메틸실록산 | - | 288 | - | - | - | |
옥타메틸시클로테트라실록산 | - | - | 312 | - | - | |
메틸페닐폴리실록산 | - | - | - | - | 312 | |
(2) | 에틸트리실록산 | 120 | - | - | 120 | - |
디메티콘 | - | 192 | - | - | - | |
메틸트리메티콘 | - | - | 168 | - | - | |
페닐트리메티콘 | - | - | - | - | 168 | |
(3) | 에탄올 | 3200 | 3200 | 3200 | 3200 | 3200 |
(4) | 염산테르비나핀 | 45 | 45 | 45 | 45 | 45 |
(5) | 엘-멘톨 | 120 | 120 | 120 | 100 | 120 |
토코페롤아세테이트 | - | - | - | 20 | - | |
(6) | 트란스큐톨 | - | 55 | - | - | - |
이소프로필미리스테이트 | 55 | - | - | - | 55 | |
프로필렌카보네이트 | - | - | 55 | - | - | |
n-메틸피롤리돈 | - | - | - | 55 | - | |
(7) | 하이드록시프로필셀룰로오스 | 100 | 90 | 100 | 100 | 90 |
에틸셀룰로오스 | - | 10 | - | - | 10 |
|
표준액 |
시험종료후 샘플(대조제제) |
시험종료후 샘플(실시예 1) |
||||
샘플 1 | 샘플 2 | 샘플 3 | 샘플 1 | 샘플 2 | 샘플 3 | ||
실험종료 후 샘플량 | 15.88mg | 15.80mg | 15.86mg | 15.18mg | 15.97mg | 14.26mg | |
피크면적 | 8711.77 | 4507.27 | 4424.30 | 4205.83 | 2652.29 | 2495.20 | 1698.44 |
잔류량(mg) | 0.224 | 0.109 | 0.108 | 0.102 | 0.067 | 0.060 | 0.046 |
예상피부흡수량(중량%) | - | 8.54 | 8.90 | 14.66 | 41.38 | 52.90 | 54.00 |
Claims (8)
- 테르비나핀 또는 약학적으로 허용가능한 염, 및 피부 도포시 피막을 형성하는 트리메틸실옥시실리케이트를 포함하는 속효성의 서방성 항진균 조성물.
- 제1항에 있어서, 상기 테르비나핀 또는 약학적으로 허용가능한 염은 테르비나핀 염산염인 항진균 조성물.
- 제1항에 있어서, 상기 테르비나핀 또는 약학적으로 허용가능한 염은 조성물 총 중량 중 0.1 ~ 20중량%인 항진균 조성물.
- 삭제
- 삭제
- 제1항 내지 제3항 중 어느 한 항에 있어서, 상기 트리메틸실옥시실리케이트는 조성물 총 중량 중 1 ~ 25중량%인 항진균 조성물.
- 삭제
- 제1항 내지 제3항 중 어느 한 항에 있어서, 상기 조성물은 겔, 크림, 로션, 액제 또는 연고의 형태인 항진균 조성물.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090025399A KR100979347B1 (ko) | 2009-03-25 | 2009-03-25 | 항진균 조성물 |
PCT/KR2009/006323 WO2010110518A1 (ko) | 2009-03-25 | 2009-10-30 | 항진균 조성물 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090025399A KR100979347B1 (ko) | 2009-03-25 | 2009-03-25 | 항진균 조성물 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR100979347B1 true KR100979347B1 (ko) | 2010-08-31 |
Family
ID=42760271
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020090025399A KR100979347B1 (ko) | 2009-03-25 | 2009-03-25 | 항진균 조성물 |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR100979347B1 (ko) |
WO (1) | WO2010110518A1 (ko) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012070798A2 (en) * | 2010-11-24 | 2012-05-31 | Yuhan Corporation | Topical antifungal composition comprising terbinafine or its salt |
WO2014126370A1 (en) | 2013-02-13 | 2014-08-21 | Dong-A Pharmaceutical Co.,Ltd | Film-forming pharmaceutical composition for wound healing and method for preparing the same |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20040101301A (ko) * | 2002-03-11 | 2004-12-02 | 다우 코닝 코포레이션 | 국소 피부 사용 및 치료용 제제 |
US20070292355A1 (en) | 2002-10-25 | 2007-12-20 | Foamix Ltd. | Anti-infection augmentation foamable compositions and kit and uses thereof |
KR20090015989A (ko) * | 2006-05-23 | 2009-02-12 | 다우 코닝 코포레이션 | 활성제를 전달하기 위한 신규한 실리콘막 형성제 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5300299A (en) * | 1991-07-22 | 1994-04-05 | Dow Corning Corporation | Silicone pressure sensitive adhesive containing alkylmethylsiloxane wax and related methods and devices |
US6538039B2 (en) * | 1994-04-29 | 2003-03-25 | Laboratoire L. Lafon | Pharmaceutical dosage form for transdermal administration |
DE10035991A1 (de) * | 2000-07-24 | 2002-02-14 | Polichem Sa | Nagellackzusammensetzung |
-
2009
- 2009-03-25 KR KR1020090025399A patent/KR100979347B1/ko active IP Right Grant
- 2009-10-30 WO PCT/KR2009/006323 patent/WO2010110518A1/ko active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20040101301A (ko) * | 2002-03-11 | 2004-12-02 | 다우 코닝 코포레이션 | 국소 피부 사용 및 치료용 제제 |
US20070292355A1 (en) | 2002-10-25 | 2007-12-20 | Foamix Ltd. | Anti-infection augmentation foamable compositions and kit and uses thereof |
KR20090015989A (ko) * | 2006-05-23 | 2009-02-12 | 다우 코닝 코포레이션 | 활성제를 전달하기 위한 신규한 실리콘막 형성제 |
Non-Patent Citations (1)
Title |
---|
International Journal of Pharmaceutics 203: 149-157 (2000) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012070798A2 (en) * | 2010-11-24 | 2012-05-31 | Yuhan Corporation | Topical antifungal composition comprising terbinafine or its salt |
WO2012070798A3 (en) * | 2010-11-24 | 2012-08-09 | Yuhan Corporation | Topical antifungal composition comprising terbinafine or its salt |
WO2014126370A1 (en) | 2013-02-13 | 2014-08-21 | Dong-A Pharmaceutical Co.,Ltd | Film-forming pharmaceutical composition for wound healing and method for preparing the same |
US10278928B2 (en) | 2013-02-13 | 2019-05-07 | Dong-A Pharmaceutical Co., Ltd | Film-forming pharmaceutical composition for wound healing and method for preparing the same |
Also Published As
Publication number | Publication date |
---|---|
WO2010110518A1 (ko) | 2010-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4825305B2 (ja) | 経皮吸収製剤 | |
US8741332B2 (en) | Compositions and methods for dermally treating neuropathic pain | |
CA2904507C (en) | Topical compositions and methods of treatment of topical disorders | |
CA2528360C (en) | Anesthetic composition for topical administration comprising lidocaine, prilocaine and tetracaine | |
EP3380080B1 (en) | Topical film-forming spray | |
JP2014001218A (ja) | 薬物の皮膚送達のための接着性外皮形成製剤とそれを使用する方法 | |
US20090042950A1 (en) | Transdermal topical composition and its uses | |
PT503988E (pt) | Composicoes para o tratamento de onicomicoses | |
TW200836769A (en) | Topical pharmaceutical formulation | |
WO2008021847A2 (en) | Topical formulation of multilamellar vesicles composition for percutaneous absorption of pharmaceutically active agent | |
TR201808178T4 (tr) | Aktif ajanların transdermal dağıtımı için bileşimler. | |
CA3020157C (en) | Topical composition comprising tacrolimus | |
JP2000143540A (ja) | 非ステロイド系消炎鎮痛薬含有外用剤 | |
US20080138391A1 (en) | Skin-friendly drug complexes for transdermal administration | |
JP4195178B2 (ja) | 消炎鎮痛外用剤 | |
HU226122B1 (en) | Pharmaceutical composition in gel form for topical use containing nimesulide and process for preparation thereof | |
EP2910254B1 (en) | Base and external preparation for skin | |
KR100979347B1 (ko) | 항진균 조성물 | |
KR20070059079A (ko) | 경피 페로스피론 투여용 의약적 조성물 | |
EP0535237A1 (en) | Composition for relieving skin irritation and external preparation for percutaneous adminstration containing the same | |
KR20110109250A (ko) | 수성/비수성 약물전달에 적용 가능한 고분자 혼합물을 이용한 고분자 수성 혼합용액으로 만들어진 필름 형성제 조성물 및 그의 제조방법 | |
TW200524635A (en) | Transdermal pharmaceutical formulations | |
WO2001043736A1 (fr) | Medicaments permettant de soulager l'hemicranie | |
EP4285931A1 (en) | Composition for external application | |
JP2024507011A (ja) | エマルション組成物、ならびに放射線によって引き起こされる皮膚損傷の予防および/または処置におけるその使用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
A302 | Request for accelerated examination | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
AMND | Amendment | ||
J201 | Request for trial against refusal decision | ||
B701 | Decision to grant | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130513 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20140408 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20150609 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20160620 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20170608 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20180807 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20190822 Year of fee payment: 10 |